• Revenue growth guidance: Happiest Minds increased its FY27 growth guidance from 10% to 12.5% and targeted 15% growth for FY28, underpinned by bottom-up account planning and large deal closures.
• AI business impact: Client demand for legacy application modernization and SDLC automation is offsetting AI-driven productivity deflation, yielding new opportunities including a million-dollar-plus agentic AI deal.
• EBITDA margin target: The company is maintaining its 20% to 22% EBITDA margin band as prior investments in the generative AI business unit and the $3 million NN sales team begin to break even and utilization recovers to 78.5–79%.
• Platform investment strategy: Additional operational gains will be reinvested into proprietary solutions, such as a healthcare multi-omics platform, to create non-linear revenue streams.